The Prostate Cancer Foundation is hosting a Zoom webinar at 4:30 p.m., Pacific Standard Time (Los Angeles) on Tuesday, 17 January 2023 to talk about rising PSA after treatment. The webinar is free and open to all, but you must register in advance.
You can send questions in advance to: webinar@pcf.org.
If you can’t attend, the webinar will be recorded so you can view it on their website later.
I stumbled across this presentation in my YouTube feed and even though it’s about 10 years old, it contains a lot of good information for those with an increasing PSA after radical prostatectomy.
It gets into:
Biochemical Recurrence definition
Value of regular vs. ultra PSA tests
Survival
Imaging (again, dated because this is 10 years old)
Identifying good candidates for salvage therapy
Salvage RT toxicities and success rates
The video is about 52 minutes long, and the presenter shares information in an understandable way for us patients.
Here’s the second part of Dr. Kwon’s video. Like the first video, it’s very informative (perhaps even more so, at least for me).
Even though I had seen similar statistics before, one of the kickers for me is that only 33% of recurrent cancer is found in the prostate bed (local); 45% will be metastatic; and 22% will be both local and metastatic. As Dr. Kwon rightly points out, knowing where the cancer is located will guide your treatment decisions, and that’s why I have been so reluctant to blindly step into salvage radiation therapy without having first identified the location of the cancer. Why risk the possible toxic side effects of radiation if you’re not radiating in the correct location?
In my previous post, I mentioned that Dr. Kwon was a pioneer in dealing with oligometastatic prostate cancer. At the beginning, many in the profession dismissed his work out of hand (I’ll admit I was skeptical, too), but it seems that over the last 10 years, his work has gained the respect of others and is supported by further research.
In any case, this video is 31 minutes long and I encourage you to watch it.